Biotech
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/20/15 -- Med BioGene Inc. ("MBI" or the "Company") (TSX VENTURE: MBI) is pleased to announce that, subject to regulatory approv ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/20/15 -- Theratechnologies Inc. (TSX: TH) today held its annual meeting of shareholders, chaired by Dawn Svoronos, chair of the board of Theratechnologies.Dur ...
GEORGE TOWN, GRAND CAYMAN: Findings Support Potential for First Once-Daily Nebulized LAMA in COPD; Initiation of Phase 3 Registrational Trials Planned for 2015 ...
LAVAL, QUEBEC: - PBI-4050 compares favorably to Nintedanib in lung fibrosis pre-clinical model - PBI-4050 shown to reduce key pro-fibrotic markers in lung fibrosis - PBI-4050 currently in phase II clinical trial in ...
ATLANTA, GA: ATLANTA, GA -- (Marketwired) -- 05/19/15 -- . (OTCQB: GOVX), a biotechnology company developing innovative human vaccines against Ebola virus and HIV using its novel platform technology, today announ ...
LAVAL, QUEBEC: - Provides ProMetic with additional cGMP, FDA-licensed manufacturing capacity of up to 250,000 liters of plasma processing per annum - Enables the acceleration of additional IND filings - Technology t ...
VANCOUVER, BRITISH COLUMBIA: Internationally-Recognized Life Sciences Executive Joins the Advisory Board of Canadian Company Specializing in Biomedical Technologies for Obesity & Diabetes ...
NORWOOD, MA: Phase 2 Clinical Study in Cystic Fibrosis Expected to Commence in 3Q 2015 ...
SEATTLE, WA: SEATTLE, WA -- (Marketwired) -- 05/18/15 -- (NASDAQ: ATOS) announced today that it will host a conference call to discuss corporate developments following the market close, today, Monday, May 18, 20 ...
GEORGE TOWN, GRAND CAYMAN: Velusetrag Improved Gastric Emptying Time Across All Doses vs. Placebo; Velusetrag Produced a Clinically Meaningful Improvement in Gastric Emptying Time in Both Diabetic and Idiopathic Gastroparetic P ...
SEATTLE, WA: Sixteen Completed Clinical Studies Provide Support for Phase 2 Program ...
SAN FRANCISCO, CA and TOKYO, JAPAN: SAN FRANCISCO, CA and TOKYO, JAPAN -- (Marketwired) -- 05/17/15 -- Medivation, Inc. (NASDAQ: MDVN) and Astellas Pharma Inc. (TSE: 4503) today announced data from the Phase 2 STRIVE trial comparing en ...
MONTREAL, CANADA: MONTREAL, CANADA -- (Marketwired) -- 05/15/15 -- Theratechnologies Inc. (TSX: TH) today announced that the Superior Court of Quebec has authorized 121851 Canada Inc. to discontinue all class action ...
LYON, FRANCE: Product Revenue Guidance for 2015 of $170-$185 Million Reaffirmed; Conference Call With Management to Take Place at 10:00 AM ET on May 15, 2015 ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/14/15 -- Dr. Christopher Andrews, M.D., MSc, FRCPC, a highly-respected Gastroenterologist, faculty member of the Department of Medicine at the Univ ...
NORWOOD, MA: Dr. Serhan Is a Leading Scientific Authority in Inflammatory Resolution ...
OREM, UT: OREM, UT -- (Marketwired) -- 05/14/15 -- Reflect Scientific, Inc. (OTCQB: RSCF), a provider of diverse products and services for the biotechnology, pharmaceutical and transportation industries, annou ...
VANCOUVER, BRITISH COLUMBIA: VANCOUVER, BRITISH COLUMBIA -- (Marketwired) -- 05/14/15 -- GLG Life Tech Corporation (TSX: GLG) ("GLG" or the "Company"), a global leader in the agricultural and commercial deve ...
